April 20th 2022
Two multiple sclerosis experts discuss long-term and real-world data with oral therapies in the treatment of relapsing-remitting multiple sclerosis (RRMS) that was presented at ACTRIMS 2022.
March 29th 2022
Experts in sleep medicine provide key insights on a series of patient cases and evaluate the use of novel agents in the treatment landscape for narcolepsy.
March 24th 2022
Expert neurologists examine strategies for optimizing treatment formulations in the management of OFF episodes in Parkinson disease and highlight the importance of patient education.
March 10th 2022
Klaus Schmierer, MB BS, PhD, FRCP, discusses how patients with multiple sclerosis have been impacted by the COVID-19 pandemic, including guideline recommendations regarding vaccinations.
February 21st 2022
Two experts discuss what it means to have an off-episode as a patient with Parkinson’s disease, as well as how to live with them and what can be done to alleviate adverse events.
January 25th 2022
Alireza Atri, MD, PhD, discusses the many methods of testing and forming a diagnosis for patients with Alzheimer’s disease, highlighting the recent FDA approval of aducanumab and its impact.
December 23rd 2021
Jeffrey L. Cummings, MD, ScD, discusses the Alzheimer’s disease and the advances recently made to improve the treatment landscape, specifically with aducanumab.
November 17th 2021
David Kudrow, MD, provides a discussion on the available treatment options for migraine management and prevention.
November 15th 2021
Elizabeth Thiele, MD, PhD, and Elaine C. Wirrell, MD, discuss the rare pediatric epilepsy conditions Dravet syndrome and Lennox-Gastaut syndrome, from prevalence to the approval of new therapies.